Considerations for the rational design of a Chlamydia vaccine

@article{Liang2017ConsiderationsFT,
  title={Considerations for the rational design of a Chlamydia vaccine},
  author={Steven Liang and David C. Bulir and C. Kaushic and J. Mahony},
  journal={Human Vaccines & Immunotherapeutics},
  year={2017},
  volume={13},
  pages={831 - 835}
}
  • Steven Liang, David C. Bulir, +1 author J. Mahony
  • Published 2017
  • Medicine
  • Human Vaccines & Immunotherapeutics
  • ABSTRACT Chlamydia trachomatis is the leading cause of preventable blindness and the most common bacterial sexually transmitted infection. Remarkable progress in vaccine research over the past six decades has led to the advancement of novel C. trachomatis vaccine candidates into clinical trials. However, many questions regarding the role of specific cellular populations and molecular mechanisms in protective immunity against human C. trachomatis genital tract infections remain unanswered… CONTINUE READING
    Update on Chlamydia trachomatis Vaccinology
    • 41
    • Open Access
    Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles
    • 9
    • Highly Influenced
    • Open Access
    Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 39 REFERENCES
    A Predominant Role for Antibody in Acquired Immunity to Chlamydial Genital Tract Reinfection1
    • 194
    • Open Access
    Vaccination against Chlamydia Genital Infection Utilizing the Murine C. muridarum Model †
    • 91
    • Open Access